
---
title: Tumors (Neoplasms)
markmap:
  colorFreezeLevel: 6
---

## Tumors (Neoplasms)

- **Basic Concepts**
  - Definition: Abnormal mass of tissue
  - Nomenclature
    - Benign (-oma: Adenoma, Papilloma, Lipoma)
    - Malignant (Carcinoma, Sarcoma, Leukemia, Lymphoma)
  - Benign vs Malignant
    - Differentiation & Anaplasia
    - Growth Rate
    - Local Invasion
    - Metastasis (Hallmark of Malignancy)

- **Epidemiology & Risk Factors**
  - Age, Genetics, Environment
  - Carcinogens
    - Chemical (Smoking, Asbestos)
    - Radiation (UV, Ionizing)
    - Microbial
      - HPV (Cervix, Anogenital, Head/Neck)
      - EBV (Nasopharyngeal CA, Lymphoma)
      - HBV/HCV (Hepatocellular CA)
      - H. pylori (Gastric AdenoCA, Lymphoma)

- **Pathogenesis (Molecular Basis)**
  - Hallmarks of Cancer (Evans & Weinberg)
    - Sustained Proliferation
    - Evading Growth Suppressors
    - Resisting Cell Death (Apoptosis)
    - Replicative Immortality
    - Angiogenesis
    - Invasion & Metastasis
    - Genome Instability
    - Inflammation (Tumor Promoting)
  - Key Genes
    - **Oncogenes** (Gain-of-Function, Activating mutations)
      - EGFR, KRAS, BRAF, HER2/Neu (ERBB2), MYC, ABL, RAS, RET, KIT
    - **Tumor Suppressor Genes** (Loss-of-Function, Two-hit hypothesis)
      - p53 (TP53), RB, APC, VHL, WT1, PTEN, BRCA1/BRCA2, NF1/NF2
    - Genes Regulating Apoptosis (BCL2 - anti-apoptotic)

- **Diagnosis**
  - Morphology (Gross & Microscopic)
    - Differentiation
    - Pleomorphism
    - Mitotic Activity (Atypical mitoses)
    - Necrosis, Hemorrhage
    - Stroma (Desmoplasia)
    - Dysplasia (Pre-malignant change)
  - Immunohistochemistry (IHC)
    - Lineage Markers (CK, Vimentin, Desmin, GFAP, S100, LCA)
    - Specific Markers (ER/PR/HER2 - Breast, PSA - Prostate, TTF1 - Lung, CD markers - Lymphoma/Leukemia)
    - Proliferation Index (Ki67)
  - Molecular Diagnostics
    - PCR, FISH, Sequencing
    - Gene rearrangements (Translocations: CML t(9;22) BCR-ABL, Burkitt t(8;14) MYC, Follicular t(14;18) BCL2, Mantle t(11;14) Cyclin D1)
    - Mutations (EGFR, KRAS, BRAF, GIST-KIT)
  - **Grading:** Histological assessment (Differentiation, Mitotic count, Nuclear atypia)
  - **Staging:** Extent of spread (TNM system: Tumor, Node, Metastasis) - Most important prognostic factor

- **Clinical Aspects & Complications**
  - Local Effects (Compression, Obstruction, Ulceration)
  - Systemic Effects (Cachexia, Fever, Anemia)
  - **Paraneoplastic Syndromes** (Tumor effects distant from primary/metastases, mediated by hormones/peptides)
    - Cushing's (ACTH - Small Cell Lung CA)
    - Hypercalcemia (PTHrP - Squamous Cell CA Lung, Renal, Breast)
    - SIADH (ADH - Small Cell Lung CA)
    - Hypoglycemia (IGF-2 - Mesenchymal tumors)
    - Myasthenia Gravis (Thymoma)
    - Acanthosis Nigricans (Gastric, Lung, Uterine CA)
    - Polycythemia (Erythropoietin - Renal Cell CA, Hemangioblastoma)
    - Hypertrophic Osteoarthropathy (Lung CA)
    - Venous Thrombosis (Trousseau's syndrome - Pancreas, Lung CA)

- **Specific Tumor Categories (High-Yield INICET)**
  - Carcinomas (Epithelial origin) - Adenocarcinoma, Squamous Cell Carcinoma, Transitional Cell Carcinoma
  - Sarcomas (Mesenchymal origin) - Osteosarcoma, Leiomyosarcoma, Rhabdomyosarcoma, Liposarcoma
  - Hematological Malignancies - Leukemias (AML, ALL, CML, CLL), Lymphomas (Hodgkin, Non-Hodgkin), Multiple Myeloma
  - CNS Tumors (Astrocytoma, Glioblastoma Multiforme, Meningioma, Medulloblastoma)
  - Pediatric Tumors (Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Retinoblastoma)
  - Germ Cell Tumors (Testis, Ovary, Mediastinum) - Seminoma, Teratoma, Yolk Sac Tumor, Choriocarcinoma
  - Melanoma

- **Cancer Genetics Syndromes**
  - Li-Fraumeni (TP53 mut) - Sarcomas, Breast, Adrenal, Leukemias
  - FAP (APC mut) - Colorectal polyps/CA, Desmoids
  - HNPCC/Lynch (Mismatch Repair mut) - Colorectal, Endometrial, Ovarian, Urothelial CA
  - Neurofibromatosis Type 1 (NF1 mut) - Neurofibromas, Optic glioma, Schwannoma
  - Neurofibromatosis Type 2 (NF2 mut) - Bilateral Acoustic Neuromas (Schwannomas), Meningioma
  - VHL (VHL mut) - Renal Cell CA, Hemangioblastoma (CNS, Retina), Pheochromocytoma

- **INICET Buzz Words:**
  - Anaplasia, Dysplasia, Carcinoma in situ
  - Metastasis: Lymphatic (Carcinomas), Hematogenous (Sarcomas, Renal, Hepatic, Follicular Thyroid)
  - Desmoplasia (Fibrous stroma)
  - Tumor Microenvironment
  - E-cadherin loss (Invasion)
  - IHC markers: CK, Vimentin, S100, LCA, GFAP, Desmin, CD markers, Ki67
  - Translocations: t(9;22) CML, t(8;14) Burkitt, t(14;18) Follicular, t(11;14) Mantle Cell
  - Mutations: EGFR, KRAS, BRAF, KIT, TP53
  - Two-Hit Hypothesis (Knudson)
  - Warburg Effect (Aerobic Glycolysis)
  - Paraneoplastic Syndromes (Specific associations)
  - TNM Staging
  - Grading (Well/Mod/Poorly Differentiated)
  - WT1 (Wilms), N-MYC (Neuroblastoma)
  - Vimentin + CK co-expression (Synovial Sarcoma)
